[go: up one dir, main page]

TWI239842B - Minoxidil-containing preparation - Google Patents

Minoxidil-containing preparation Download PDF

Info

Publication number
TWI239842B
TWI239842B TW090108343A TW90108343A TWI239842B TW I239842 B TWI239842 B TW I239842B TW 090108343 A TW090108343 A TW 090108343A TW 90108343 A TW90108343 A TW 90108343A TW I239842 B TWI239842 B TW I239842B
Authority
TW
Taiwan
Prior art keywords
composition
minoxidil
patent application
scope
item
Prior art date
Application number
TW090108343A
Other languages
English (en)
Inventor
Koji Imamura
Rumi Ochiai
Takako Okajima
Susumu Morioka
Taro Horie
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of TWI239842B publication Critical patent/TWI239842B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966Triazines or their condensed derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Description

A7 經濟部智慧財產局員工消費合作社印製 1239842 B7 五、發明説明(彳) 本發明係關於防止經時著色之含有米諾地爾的組成物 【先行技術】 米諾地爾因爲其育毛效果,而被期待爲外用育毛劑之 成份。 惟,於溶液狀態下保存的米諾地爾,因容易有經時著 色之缺點,可能造成商品價値低下。 【發明所欲解決之課題】 本發明係防止配合米諾地爾之組成物著色爲目的。 【用以解決課題之手段】 一般,配合容易著色成份的液劑時,被考量配合二丁 基羥基甲苯等抗氧化劑使其改善。本發明者發現含有米諾 地爾之液劑中配合二丁基羥基甲苯等抗氧化劑也幾乎無法 防止著色,或者不但沒有防止著色反而使之增強一事。 於此,爲解決此問題而經精密硏究結果,藉由調整含 有米諾地爾之液劑組成物的p Η爲5 . 5〜7 . 0時,發 現不但改善上述之不利點,並能使液劑著色防止/效果顯著 向上,進而完成本發明。 亦即,本發明爲配合抗氧化劑且ρ Η爲5 . 5〜 7 · 0之含有米諾地爾的組成物。 又,本發明爲配合二丁基羥基甲苯或丁羥基苯甲醚 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐)~' — ' -4 - (請先閱讀背面之注意事項再填寫本頁)
經濟部智慧財產局員工消費合作社印製 1239842 A7 _ B7 五、發明説明(2 ) pH爲5 · 5〜7 · 0之含有米諾地爾的組成物。 又,本發明爲於含有米諾地爾的組成物中,配合抗氧 化劑,且P Η爲5 · 5〜7 · 〇爲特徵之組成物的著色防 止方法。 【發明之實施之形態】 於本發明中使用的抗氧化劑係由,二丁基羥基甲苯, 丁羥基苯甲醚,異抗壞血酸,EDTA—2Na ,檸檬酸 異丙酚,沒食子酸丙酯,愈瘡木酸,α -硫甘油,二氯化 異氰尿酸鉀,2 ’ 6 —二第三丁基—4 一甲酚,大豆卵磷 脂,氫硫基乙酸鈉,硫代蘋果酸鈉,軟脂酸抗壞血酸脂, 2 -氫硫基苯并咪唑,羥基喹啉硫酸鹽,所成群當中選出 一種或二種爲理想。又,抗氧化劑也可使用生藥萃取物, 特別是丁香,老鸛草,大黃,黃柏,芍藥,牡丹皮,黃連 ,陳皮,蛇麻草,黃芩,桂皮,甘草,桔梗,生薑,紅花 ,當歸的萃取物,所成物當中選出一種或二種爲理想。這 些生藥萃取物可由水,碳素數2〜4的乙醇(例如:乙醇 ,丙二醇,1 ,3 — 丁二醇,甘油等)或者是其混合溶媒 爲抽出溶媒使用時取得。 本組成物中之抗氧化劑的配合量以米諾地爾1質量部 對0 · 0 0 5〜0 · 5質量部爲理想,而更理想者爲 〇 · 0 1〜0 · 5質量部。因抗氧化劑的種類而有所不同 ,但沒有添加足夠的量時,就算Ρ Η在5 . 5〜Τ7 . 0的 範圍內也會使著色增強。 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) (請先閱讀背面之注意事項再填寫本頁)
-5- 1239842 A7 B7 五、發明説明(3 ) ^ 本發明的組成物由p Η越低著色防止效果越小一事, Ρ Η在5 · 5以上爲理想,而更理想者爲5 · 7以上。 (請先閱讀背面之注意事項再填寫本頁) 又’由米諾地爾的溶解性之點,ρ Η在7 · 0以下爲 理想,而更理想者爲6 · 3以下。 於本發明的組成物之ρ Η調整可用通常被使用之ρ Η 調整劑,具體而言,例如:檸檬酸,蘋果酸,乳酸等有機 酸,和磷酸,鹽酸,硫酸等無機酸可被列舉出。 本發明的組成物之米諾地爾的濃度以組成物全體的1 〜1 0質量%爲理想, 更理想者爲3〜6質量%。 本發明的組成物以配合多價乙醇或聚乙二醇爲溶媒者 較理想。 多價乙醇以丙二醇,一縮二丙二醇,1 ,3 — 丁二醇 ,甘油,己二醇,聚乙二醇爲理想,而更理想者爲1 ,3 —丁二醇。聚乙二醇以 Macrogoul 2 0 0 及 Macrogoul 4 0 0爲理想。多價乙醇的配合量以米諾地爾1質量部對1〜 5〇質量部爲理想。 經濟部智慧財產局員工消費合作社印製 本發明的組成物之形態,並無特別限定,舉凡乳液劑 ,氣溶膠劑,凝膠劑等任何一種皆可,.其製造方法可由醫 藥品或化妝用料之製劑化的一般方法調製而成。 又,本發明的組成物可應需要,配合溶解補助劑(脂 肪酸酯,多價乙醇脂肪酸酯,中鏈脂肪酸甘油酯,植物油 ,烷基甘油醚),界面活性劑(非離子性界面活性劑,卵 磷脂誘導體,高分子乳化劑)’乳化安定劑,吸收促進劑 本紙張尺度適用中國國家標準(CNS ) A4規格(210Χ297公釐) - ' -6 - 1239842 Α7 Α7 Β7 五、發明説明(4 ) 等。 【發明之效果】 根據本發明,可能提供長期防止著色之含有米諾地爾 的組成物。 實施例 以下,藉由實施例以及試驗例進行本發明更詳細之說 明。又,pH爲使用由玻璃電極之PH計(東亞電波工業 製),針對製劑5 in L測定5分鐘後之ρ Η。 實施例1 於米諾地爾5g ,1 ,3 — 丁二醇30g ,乙醇5〇 g,二丁基羥基甲苯0 · 5g中添加磷酸〇 · 5mL,用 精製水使其總量爲1 〇 〇 m L,攪拌溶解調製成乳液狀的 組成物。組成物的P Η爲6 ·〇。 實施例2 於米諾地爾5 g,1 ,3 - 丁二醇3 〇 g ,乙醇5 0 g,二丁基羥基甲苯0 · lg中添加磷酸〇 · 9mL,用 精製水使其總量爲1 0 0 m L· ’攪拌溶解調製成乳液狀的 組成物◦組成物的P Η爲5 · 5。 實施例3 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公嫠) (請先閱讀背面之注意事項再填寫本頁) 訂 %· 經濟部智慧財產局員工消費合作社印製 A7 1239842 B7 五、發明説明(5 ) 於米諾地爾,1 ,3 一丁一醇3〇g ,乙醇5〇 (請先閱讀背面之注意事項再填寫本頁) g,二丁其声基甲笨0 · 5g中添加檸檬酸〇 · 55g , 用精製水使其總纛爲1 0 0 m L ’擾拌溶解調製成乳液狀 的組成物。組成物的p Η爲6 · 4。 實施例4 於米諾地爾32 ,1 ,3 — 丁一醇30g ,乙醇5〇 g ,丁羥基苯甲醚0 · 5g中添加碟酸0 · 02mL ’用 精製水使其總量爲1 0 0 m L ’攪拌溶解調製成乳液狀的 組成物。組成物的P H爲7 · 0 ° 實施例5 於米諾地爾5S ’丙二醇52S ’乙醇25§ ’二丁 基羥基甲苯0 . 5S ’添加磷酸〇 · 3mL ’用精製水使 其總量爲1 0 0 m L ’ « 容角f胃_ $ 1 '液H犬0勺$且/¾ % ° 組成物的P Η爲6. · 〇 ° 經濟部智慧財產局員工消費合作社印製 比較例1 於米諾地爾3 g ’ 1 ’ 3 — 丁二醇3 0 g ,乙醇5 〇 g,二丁基羥基甲苯〇 · 5g中添加.精製水’使其總量爲 1 〇 〇 m L,攪拌溶解調製成乳液狀的組成物。組成物的 p Η 爲 8 · 8。 比較例2 _________________— 本紙張尺度適用中國國家標準(CNS) Α4規格(210x297公釐) 1239842 A7 __B7____ 五、發明説明(6 ) 添加米諾地爾5g ,丙二醇52g ’乙醇25g ’用 (請先閱讀背面之注意事項再填寫本頁) 精製水使其總量爲1 0 0 m L,攪拌溶解調製成乳液狀的 組成物。組成物的P Η爲8 · 7。 比較例3 於米諾地爾5 g,丙二醇5 2 g ,乙醇2 5 g ’添加 磷酸〇 · 〇 3 m L,用精製水使其總纛爲1 0 0 m L ’擾 拌溶解調製成乳液狀的組成物。組成物的P H爲6 · 0 ° 比較例4 於米諾地爾5 g,丙二醇5 2 g,乙醇2 5 g ’添加 二丁基羥基甲苯〇 · 5 g,用精製水使其總量爲1 0 0 m L,攪拌溶解調製成乳液狀的組成物。組成物的p H爲 8.7° 試驗例1 經濟部智慧財產局員工消費合作社印製 將實施例1〜4,比較例1的組成物個別塡充於保特 瓶容器內,保存於5 0 °C下1個月,進行外觀(色調)之 觀察。 外觀的評價,係根據以下基準進行。 0 :不被斷定著色,成爲商品並無問題。 1 :雖有些許著色,但成爲商品並無問題。 2 :著色被斷定,成爲商品有問題。 其結果如表1所示。 ^紙張尺度適用中國國家K( CNS ) A4規格(210X297公釐) ' ^ -9- 1239842 A7 B7 五、發明説明(7 表1 製劑例 實施例1 實施例2 1——--- 3 實施例4 比較例1 —PH 6 5.5 7 8.8 評價 0 1 1 2 經濟部智慧財產局員工消費合作社印製 比較例1中因著色被斷定而被判斷於商品性上有問題 ,於實施例1〜4的組成物不被斷定著色,或有些許著色 也被判斷成爲商品並無問題。 試驗例2 實施例5,將比較例2〜4的組成物個別塡充於保特 瓶容器內,保存於5 0 °C下1個月者以吸光高度計( B a c k m a η公司製)測定其吸光度(4 2 0 n m )。 其結果如表2所示。 表2 製劑例 實施例5 比較例2 比較例3 比較例4 pH 6 8.7 6 8.7 Β Η T 〇.5g 〇g 〇g 0.5g 吸光度(420nm) 0.013 0.021 0.058 0.039 由比較例2以及比較例3的結果顯示,使米諾地爾組 成物P Η低下時更會加強其著色。又,由比較例4的結果 得知添加Β Η Τ不但沒有防止著色反而會使著色增強一事 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)
1239842 A7 B7 五、發明説明(8 ) 防 色 著 的 佳 例 較 比 之 何 任 比 到 得 中 5 例 施 實 於 此。 對果 效 止 (請先閱讀背面之注意事項再填寫本頁) 、訂 經濟部智慧財產局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -11 -
申請曰期 90 年 4 月 6 日 案 號 90108343 類 別 (以上各攔由本局填註)AW 1239842中文說明書替換頁 民國94年1月5曰呈 α Α4 ]C4 驀4專利説明書 中 文 含有米諾地爾(Mi nox i d i 1)之製劑 發明 新型 名稱 英 文
MinoxidiI-containing preparation
I 名 姓 國 籍 二美子 康留孝 村合ig 今落岡a)ss (1)日本國東京都豊島區高田三丁目二四番一號大正製薬株式会 社内 裝 發明 創作 人 住、居所 (2)日本國東京都豊島區高田三丁目二四番一號大正製薬株式会 社内 (3)日本國東京都豊島區高田三丁目二四番一號大正製薬株式会 社内 訂 姓 名 (名稱) (1)大正製藥股份有限公司 大正製蘂株式会社 線 經濟部智慧財產局員、工消費合作社印製 國 籍 住、居所 (事務所) 代表人 姓 名 (1)日本 (1)日本國東京都豊島區高田三丁目二四番一號 ⑴上原明 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)

Claims (1)

  1. 8 8 8 8 ABCD 1239842 六、申請專利範圍 r-一·—一一 一了一一| 第90 1 08343號專利申請案 ! :..> -'--S i年n ’二'::·〉: j 中文申請專利範圍修正本 -' 民國94年1月5日修正 1 . 一種用於改善著色之組合物,其特徵爲配合1種或 2種選自二丁基羥基甲苯及丁羥基苯甲醚所成群’米諾地爾 的濃度爲3〜6質量%,pH爲5 · 5〜7 · 〇 ° 2 .如申請專利範圍第1項之組合物’其中P H爲 5 · 7 〜6 . 3。 3 .如申請專利範圍第1項或第2項之組合物’其中配 合1種或2種選自二丁基羥基甲苯及丁經基苯甲醚所成群’ 對1質量份的而言爲米諾地爾1質量部對0 · 0 0 5〜 0 . 5質量份者。 4 .如申請專利範圍第1項或第2項之組合物’其中更 配合多元醇者。 5 .如申請專利範圍第1項至第4項中任一項之組合物 ,其中更配合聚乙二醇者。 6 . —種用於改善著色之方法,其特徵爲於含有米諾地 爾的組成物中,配合1種或2種選自二丁基經基甲苯及了* ^ 基苯甲醚所成群,且pH爲5 . 5〜7 _ 〇者。 本紙張尺度適用中國國家標率(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁:> -裝* 訂 經濟部智慧財產局員工消費合作社印製
TW090108343A 2000-04-07 2001-04-06 Minoxidil-containing preparation TWI239842B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000107028A JP4780429B2 (ja) 2000-04-07 2000-04-07 ミノキシジル含有製剤

Publications (1)

Publication Number Publication Date
TWI239842B true TWI239842B (en) 2005-09-21

Family

ID=18620086

Family Applications (1)

Application Number Title Priority Date Filing Date
TW090108343A TWI239842B (en) 2000-04-07 2001-04-06 Minoxidil-containing preparation

Country Status (17)

Country Link
EP (1) EP1273299B1 (zh)
JP (1) JP4780429B2 (zh)
KR (1) KR100740393B1 (zh)
CN (1) CN1279914C (zh)
AT (1) ATE306925T1 (zh)
AU (1) AU778783B2 (zh)
BR (1) BR0109847A (zh)
CA (1) CA2405429C (zh)
DE (1) DE60114171T2 (zh)
DK (1) DK1273299T3 (zh)
ES (1) ES2250374T3 (zh)
HU (1) HUP0301124A2 (zh)
NZ (1) NZ521733A (zh)
RU (1) RU2275914C2 (zh)
TW (1) TWI239842B (zh)
WO (1) WO2001076605A1 (zh)
ZA (1) ZA200207960B (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO983897A0 (en) 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
JP5785353B2 (ja) * 2004-02-27 2015-09-30 大正製薬株式会社 眼科用剤
TW200534875A (en) * 2004-04-23 2005-11-01 Lonza Ag Personal care compositions and concentrates for making the same
JP2006022091A (ja) * 2004-06-09 2006-01-26 Dai Ichi Seiyaku Co Ltd 育毛用組成物
JP5040060B2 (ja) * 2004-10-14 2012-10-03 大正製薬株式会社 メチオニン配合内服液剤
CN101610751B (zh) * 2006-12-20 2012-03-21 大正制药株式会社 脱发症的预防或治疗剂
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
JP5286999B2 (ja) * 2008-07-10 2013-09-11 大正製薬株式会社 ミノキシジル含有液剤
MX2011003207A (es) 2008-09-27 2011-11-04 Jina Pharmaceuticals Inc Preparaciones farmaceuticas a base de lipidos para la aplicacion oral y topica; sus composiciones, metodos y usos.
US8470833B2 (en) * 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
JP6067036B2 (ja) * 2013-01-31 2017-01-25 富士フイルム株式会社 乳化組成物
JP6199066B2 (ja) * 2013-04-24 2017-09-20 ロート製薬株式会社 ミノキシジル含有外用組成物
KR101580119B1 (ko) * 2013-04-29 2015-12-29 한국유나이티드제약 주식회사 쓴맛이 차폐된 황련 추출물을 포함하는 경구투여용 제제
US9662394B2 (en) * 2013-10-03 2017-05-30 Dow Pharmaceutical Sciences, Inc. Stabilized efinaconazole compositions
CN112999223A (zh) 2013-11-22 2021-06-22 博世健康爱尔兰有限公司 抗感染的方法、组合物和装置
JP6736889B2 (ja) * 2015-01-23 2020-08-05 大正製薬株式会社 外用組成物
JP6052686B2 (ja) * 2015-02-06 2016-12-27 ダイヤ製薬株式会社 外用液剤
JP6528194B2 (ja) * 2015-02-06 2019-06-12 ダイヤ製薬株式会社 ミノキシジル含有外用液剤および外用液剤の製造方法
JP6825354B2 (ja) * 2015-12-29 2021-02-03 大正製薬株式会社 外用組成物
JP7346010B2 (ja) * 2016-09-15 2023-09-19 大正製薬株式会社 外用組成物
KR102000217B1 (ko) * 2017-08-08 2019-07-15 에스씨엠생명과학 주식회사 Cxcl1 단백질 및 미녹시딜을 유효성분으로 포함하는 탈모 예방 또는 치료용 약학적 조성물
JP2017206558A (ja) * 2017-08-22 2017-11-24 ロート製薬株式会社 ミノキシジル含有外用組成物
JP2020023467A (ja) * 2018-01-19 2020-02-13 ロート製薬株式会社 外用製剤、液切れ性を改善する方法、および、液切れ性改善剤
JP7304463B2 (ja) * 2018-01-29 2023-07-06 富士化学工業株式会社 ミノキシジル含有外用組成物
JP2019014764A (ja) * 2018-11-06 2019-01-31 ロート製薬株式会社 ミノキシジル含有外用組成物
JP7488634B2 (ja) * 2019-07-10 2024-05-22 ロート製薬株式会社 外用製剤
JP7575722B2 (ja) * 2019-10-28 2024-10-30 大正製薬株式会社 外用医薬組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601359B1 (fr) * 1986-07-09 1988-10-28 Cird Nouveaux derives bicycliques naphtaleniques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire et en cosmetique.
FR2621912B1 (fr) * 1987-10-16 1990-03-02 Oreal Nouveaux derives du norbornane, leur procede de preparation et compositions cosmetique et medicamenteuse les contenant
EP0327263B1 (en) * 1988-01-29 1994-09-07 PROCTOR, Peter H. Hair growth stimulation with nitroxide and other radicals
FR2641184B1 (fr) * 1988-12-30 1991-04-05 Oreal Composition pour induire et stimuler la croissance des cheveux et/ou freiner leur chute, a base de derives de pyrimidine et de filtres solaires
JP2511714B2 (ja) * 1989-12-05 1996-07-03 一丸ファルコス株式会社 植物由来抽出成分からなるフケ菌発育阻害剤を含有する皮膚・頭皮・頭髪用化粧料
AU697389B2 (en) * 1992-09-14 1998-10-01 Walter P. Smith Skin-conditioning composition its application and manufacture
JP4467085B2 (ja) * 1996-01-05 2010-05-26 大正製薬株式会社 ヒノキチオール含有組成物
FR2756561B1 (fr) * 1996-12-04 1999-01-08 Cird Galderma Composes heteroaryles, compositions pharmaceutiques et cosmetiques les contenant et utilisations
JPH11349451A (ja) * 1998-06-08 1999-12-21 Taisho Pharmaceut Co Ltd 育毛剤

Also Published As

Publication number Publication date
CA2405429A1 (en) 2001-10-18
DK1273299T3 (da) 2006-02-06
ES2250374T3 (es) 2006-04-16
EP1273299A1 (en) 2003-01-08
HK1056510A1 (zh) 2004-02-20
BR0109847A (pt) 2003-06-24
EP1273299A4 (en) 2003-05-14
ZA200207960B (en) 2004-01-27
RU2002126553A (ru) 2004-03-20
KR100740393B1 (ko) 2007-07-16
CN1279914C (zh) 2006-10-18
JP2001288090A (ja) 2001-10-16
JP4780429B2 (ja) 2011-09-28
KR20020087126A (ko) 2002-11-21
HUP0301124A2 (hu) 2003-08-28
DE60114171T2 (de) 2006-07-06
CA2405429C (en) 2007-09-04
CN1431903A (zh) 2003-07-23
AU778783B2 (en) 2004-12-23
EP1273299B1 (en) 2005-10-19
ATE306925T1 (de) 2005-11-15
NZ521733A (en) 2003-08-29
WO2001076605A1 (en) 2001-10-18
DE60114171D1 (de) 2006-03-02
AU4683901A (en) 2001-10-23
RU2275914C2 (ru) 2006-05-10

Similar Documents

Publication Publication Date Title
TWI239842B (en) Minoxidil-containing preparation
TWI289459B (en) Hair growth stimulant compositions
TW508245B (en) Stable topical cosmetic/pharmaceutical emulsion compositions containing ascorbic acid
TWI285551B (en) Minocycline-containing compositions
TWI240635B (en) Active vitamin D3 emulsion lotion
TWI285114B (en) Hair growth stimulant compositions with sustained action
Hosny et al. Oral gel loaded with penciclovir–lavender oil nanoemulsion to enhance bioavailability and alleviate pain associated with herpes labialis
TW440449B (en) A mixture composition of oils and water without surfactant
JPH11193208A (ja) 香料可溶化組成物及びこれを配合した外用組成物
JP4796260B2 (ja) ミノキシジル含有製剤
JPH10245315A (ja) シクロジペプタイド誘導体を含有する組成物
CN114404325A (zh) 一种可无限稀释水包油型菜籽油微乳液及其制备方法和应用
JPH0532521A (ja) ゲル状化粧料
JPH0536412B2 (zh)
JP6880871B2 (ja) エアゾール剤
JP4872153B2 (ja) 液体組成物
TWI232758B (en) High concentration vitamin C composition and method for preparing the same
JP7449692B2 (ja) 油性外用組成物
CN110799169A (zh) 化妆品
KR102390748B1 (ko) 디클로페낙 함유 유화 겔 조성물
JP2004196709A (ja) ゲル状組成物、芳香剤、皮膚外用剤及び化粧料
JP2009091341A (ja) エアゾール剤
JP6848565B2 (ja) エアゾール剤
JP4992181B2 (ja) 外用剤組成物
BRPI0617258A2 (pt) soluções aquosas escoáveis altamente concentradas de ibuprofeno de potássio suas preparações e seus usos

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees